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Several control conditions, such as penetrating sham acupuncture and non-penetrating
placebo needles, have been used in clinical trials on acupuncture effects in chronic
pain syndromes. All these control conditions are surprisingly effective with regard to
their analgesic properties. These findings have fostered a discussion as to whether
acupuncture is merely a placebo. Meta-analyses on the clinical effectiveness of placebo
revealed that placebo interventions in general have minor, clinically important effects.
Only in trials on pain and nausea, including acupuncture studies, did placebo effects vary
from negligible to clinically important. At the same time, individual patient meta-analyses
confirm that acupuncture is effective for the treatment of chronic pain, including small
but statistically significant differences between acupuncture and sham acupuncture. All
acupuncture control conditions induce de qi, a distinct stimulation associated with pain
and needling which has been shown to be a nociceptive/pain stimulus. Acupuncture
therefore probably activates the pain matrix in the brain in a bottom-up fashion via the
spino-thalamic tract. Central nervous system effects of acupuncture can be modulated
through expectations, which are believed to be a central component of the placebo
response. However, further investigation is required to determine how strong the
influence of placebo on the attenuation of activity in the pain matrix really is. A meta-
analysis of individual participant functional magnetic imaging data reveals only weak
effects of placebo on the activity of the pain network. The clinical acupuncture setting
is comprised of a combination of a distinct neurophysiological stimulus, the needling
stimulus/experience, and a complex treatment situation. A broader definition of placebo,
such as that proposed by Howick (2017) acknowledges a role for expectation, treatment
context, emotions, learning, and other contextual variables of a treatment situation. The
inclusion of particular treatment feature as a definitional element permits a contextual
definition of placebo, which in turn can be helpful in constructing future clinical trials
on acupuncture.
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THE EFFECTS OF ACUPUNCTURE AND PLACEBO IN CLINICAL
PAIN STUDIES
Clinical Acupuncture Studies on Chronic Pain Conditions
In clinical acupuncture studies on pain, acupuncture control conditions (often called sham
acupuncture) show strong clinical effects. The three most frequently applied acupuncture control
conditions are: (i) points that differ from the acupuncture points are needled; (ii) true acupuncture
points are needled, but only very gently, and with very thin needles (minimal acupuncture) and
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(iii) so-called placebo needles that do not penetrate the skin are
used (for further discussion see paragraph “Needling associated
procedures as sham acupuncture conditions in clinical trials”).
In many of these clinical pain studies on acupuncture,
acupuncture control conditions are more effective than standard
medical care. In the German Acupuncture Randomized Trials
(ART) studies, for example, in which true acupuncture was
compared with minimal acupuncture and waiting list control,
both true and minimal acupuncture were superior to being on
a waiting list for the diagnosis of migraine, tension headache,
or chronic back pain (Linde et al., 2005; Melchart et al.,
2005; Brinkhaus et al., 2006). The only exception was knee
arthritis, where only true acupuncture brought significant relief
(Witt et al., 2005).
The German Acupuncture trials (GERAC studies) followed
a slightly different design by comparing true acupuncture with
minimal-acupuncture and standard medical care (Molsberger
et al., 2006a,b). The results were similar: The treatment effect of
acupuncture or minimal acupuncture was significantly superior
to standard medical care and the effect was strong with
no significant differences between the acupuncture conditions
(Haake et al., 2007). The close similarity between true
acupuncture, sham- and minimal acupuncture has raised the
question as to whether the actual procedure of acupuncture is
a placebo. Nonetheless, one of the consequences of these trials,
which were funded by German health insurance companies, was
that acupuncture is now recognized for by many German health
insurance companies as a viable treatment for several conditions.
One of the most central questions in clinical studies is,
however, whether and how the treatment which is to be tested
compares to the available gold standard. A systematic review
(Linde et al., 2009) consisting of twenty-two trials with a total
of 4,419 patients came to the conclusion that acupuncture is not
only at least as effective for migraine prophylaxis as prophylactic
drug treatment but that it also has less side effects. Once again, no
difference was established between true acupuncture and sham
acupuncture procedures. In a systematic review on acupuncture
treatment for tension type headache (Linde et al., 2009), the trials
included were more heterogeneous (11 trials with 2,317 patients)
with regard to the control conditions while the results were less
homogeneous. The authors nonetheless came to the conclusion
that acupuncture constitutes a valuable non-pharmacological
treatment alternative.
Unlike the results from the large clinical acupuncture
studies on pain syndromes, several brain-imaging studies in
defined patient populations revealed relatively clear therapeutic
acupuncture effects. For example, acupuncture therapeutic
brain imaging studies in neuropathic pain (carpal tunnel
syndrome) (Maeda et al., 2013, 2017) showed distinct true
acupuncture-related neuroplasticity in the somatosensory cortex.
This neuroplasticity is specifically related to increased neural
functionality in the periphery (median nerve function) as well
as to symptom improvement. One particularity of these two
studies may be partly due to the use of electro acupuncture which
constitutes a somewhat powerful acupuncture treatment.
In conclusion, the fact that sham acupuncture was equally
effective as true acupuncture in almost all of the clinical trials on
acupuncture has fostered a discussion as to whether acupuncture
constitutes a particularly effective placebo, or whether sham
acupuncture is an inadequate control.
How Powerful Is Placebo?
Meta-Analyses on Clinical Placebo
Effects
At the same time, the placebo effect, and in particular its potential
clinical relevance was under discussion. While basic scientists
claimed that a strong placebo effect existed (Benedetti et al.,
2005), the authors of the first major Cochrane review on the
topic (Hrobjartsson and Gotzsche, 2003), concluded that there
was no evidence to suggest that placebo interventions have
clinically important effects in general. Moreover, in the only
clinical condition in which a significant placebo effect could
be detected, i.e., pain, the result was restricted to subjective
continuous outcomes, and could not be clearly distinguished
from bias (Hrobjartsson and Gotzsche, 2003). The authors came
to the same conclusion after incorporating new evidence and
trials (Hrobjartsson and Gotzsche, 2004a,b). Despite extending
the search to more clinical conditions, the conclusion that
placebo interventions in general have no important clinical effects
still prevailed (Hrobjartsson and Gotzsche, 2010).
However, on the basis of the new data material, the authors
qualified their conclusion as follows: “in certain settings placebo
interventions can influence patient-reported outcomes, especially
pain and nausea, though it is difficult to distinguish patient-
reported effects of placebo from biased reporting. The effect
on pain varied, even among trials with low risk of bias, from
negligible to clinically important. Variations in the effect of
placebo were partly explained by variations in how trials were
conducted and how patients were informed” (Hrobjartsson and
Gotzsche, 2010). It is important to bear in mind that, since these
meta-analyses contained acupuncture trials, in particular with
regard to pain, they included and calculated sham- acupuncture
conditions as placebo interventions. As discussed later in more
detail, non-pharmacological placebos such as sham acupuncture
as well as sham surgery maybe clinically more effective than
oral pharmacological placebos (Meissner et al., 2013). This
has certainly been the case in trials on migraine prophylaxis
using network meta-analysis. The interpretation that the effect
of non-pharmacological placebos is similar to pharmacological
placebos may, therefore, be misleading and may undermine the
effectiveness of the verum condition, here true acupuncture.
Consequently, the discussion on the relevance of placebo
in general – and its role for acupuncture in particular – was
intense and at times heated (Hrobjartsson and Gotzsche, 2006).
Nonetheless, even a meta-analysis on acupuncture treatment
for pain which included a systematic review of randomized
clinical trials with true acupuncture, sham acupuncture, and
no acupuncture groups did not reach any conclusion (Madsen
et al., 2009). The aim was to explore the analgesic effect of
acupuncture and sham acupuncture and to ascertain whether
the type of the placebo acupuncture applied is associated
with the estimated effect of acupuncture. Only three-armed
randomized clinical trials consisting of a true acupuncture,
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a sham acupuncture (or other similar controls), and a non-
acupuncture group were included. However, this did not
alter the results and conclusion: “A small analgesic effect
of acupuncture was found, which seems to lack clinical
relevance and cannot be clearly distinguished from bias. Whether
needling at acupuncture points, or at any site, reduces pain
independently of the psychological impact of the treatment
ritual is unclear” (Madsen et al., 2009). The general conclusion
from meta-analytic approaches to placebo is therefore that
placebo effects are small, usually not clinically significant, and
that the acupuncture effects in pain trials are inconsistent,
dependent on study design and outcome, and very probably
the result of bias.
Sham Acupuncture: A Particularly
Powerful Placebo?
While several meta-analyses on acupuncture pain trials did not
differ, a meta-analyses technique combining individual patient
data (Vickers et al., 2010) came to a completely different
conclusion. The first individual patient data meta-analyses, using
data from 29 of 31 eligible RCTs, with a total of 17,922 patients,
established that acupuncture is effective for the treatment of
chronic pain (Vickers et al., 2012). Furthermore, they noted
small, but statistically significant differences between true- and
sham acupuncture. The authors state that “these differences
are relatively modest, suggesting that factors in addition to the
specific effects of needling are important contributors to the
therapeutic effects of acupuncture.” An update confirms the
results and conclusion (Vickers et al., 2017) and a further detailed
analysis of the data set suggests that the clinical benefit persists
over time (MacPherson et al., 2017).
The interpretation that acupuncture in general is a particularly
powerful placebo is predominantly due to the strong effects
of sham acupuncture conditions as control conditions in
clinical trials. Nonetheless, with regard to the question as
to the clinical relevance of these effects, the comparison of
true acupuncture/sham acupuncture conditions to other control
conditions, in particular no-treatment controls or routine care
controls, is relevant.
In their meta-analysis over 37 trials involving 5,754
patients Linde et al. (2010a) concluded that sham acupuncture
conditions have much greater non-specific effects than placebo
interventions. This meta-analysis also focused on three-armed
trials, including non-acupuncture control groups. Unlike
Madsen et al. (2009) the authors distinguished sham acupuncture
conditions from inert placebo conditions in the discussion and
raised the question as to whether sham acupuncture conditions
differ from other placebos in that the former induce particularly
large unspecific effects. Such an interpretation would have
substantial methodological consequences for the design of
clinical trials. The authors also raised the issue as to how such a
finding should be evaluated in the light of the clinical relevance
of sham acupuncture (Linde et al., 2010a,b). The same issue
was raised by Moffet (2009) who, in his systematic review, also
deemed sham acupuncture conditions to be as clinically relevant
as true acupuncture conditions.
To answer the question as to whether sham acupuncture
interventions are generally more clinically effective than other
placebos (Linde et al., 2010b), reanalyzed the data from the
Cochrane review of Hrobjartsson and Gotzsche (2010) on
placebo effects in all clinical conditions. They concluded, with all
due caution given the heterogeneity of the included trials, that
sham acupuncture conditions are in fact associated with stronger
non-specific effects than other physical and pharmacological
placebos. As already mentioned above, the phenomenon that
sham acupuncture conditions are more clinically effective than,
for example, oral placebos, was confirmed by Meissner et al.
(2013) in their elegant systematic review on the differential
effectiveness of different placebo treatments in trials on migraine
prophylaxis. This network meta-analysis revealed that both sham
acupuncture and sham-surgery were clinically more effective
than oral pharmacological placebos.
Penetrating sham acupuncture has been criticized on account
of the fact that it may actually constitute a less effective form
of acupuncture treatment. Therefore, non-penetrating devices
which mimic the acupuncture procedure but which do not
actually penetrate the skin have been developed (Streitberger and
Kleinhenz, 1998; Park et al., 2002). Nonetheless, a systematic
review by Zhang et al. (2015) reveals precisely the same effect
for non-penetrating needles as for other sham acupuncture
procedures. They conclude that neither the Streitberger nor
the Park device is an inert control intervention. Moreover,
sixteen studies recorded adverse events in true and sham
acupuncture alike.
Nonetheless, while focusing on the issue of sham acupuncture
conditions, it should be borne in mind that acupuncture has
also been shown to be clinically more effective than for example
non-steroidal anti-inflammatory drugs (NASIDs). In a study on
chronic back pain patients, Toroski et al. (2018) ascertained
that electro-acupuncture treatment was clinically effective and,
moreover, more cost effective than treatment with non-steroidal
anti-inflammatory drugs.
In summary, it is generally accepted that acupuncture is
clinically effective in treating chronic pain states. There is a
significant, but rather small difference between acupuncture
and sham acupuncture. At the same time, sham acupuncture
conditions appear to be more effective than other physical and
pharmacological placebos.
NEEDLING-ASSOCIATED PROCEDURES
SUCH AS SHAM ACUPUNCTURE
CONDITIONS IN CLINICAL TRIALS
Three frequently employed control strategies are generally
defined as sham acupuncture. Two of these methods penetrate
the skin: (i) other points than acupuncture points, are needled.
This type of control procedure is used to investigate the site
(or point)-specific effects of acupuncture (Moore and McQuay,
2005); (ii) applying minimal acupuncture; true acupuncture
points are needled, but only very gently and with extremely thin
needles. This procedure, which is used for mode-specific control
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of acupuncture effects, should enable the physician to define
the appropriate “dose” of peripheral sensory stimulation (Backer
et al., 2002). A combination of these two strategies is sometimes
used. A third procedure utilizes devices with non-penetrating
devices similar to the so-called “Streitberger needle” or the “Park-
Sham” device. These procedures are similar in that they have the
appearance of an acupuncture needle but do not penetrate the
skin (Streitberger and Kleinhenz, 1998; Park et al., 2002; Chae
et al., 2018). These devices are often called “placebo needles.”
On the basis of the findings that sham acupuncture
conditions appear to be more effective than other physical
and pharmacological placebos, the issue has been raised as
to whether sham acupuncture is physiologically active and, as
such, not acceptable as a placebo control (Birch, 2006; Langevin
et al., 2006, 2011; Lundeberg et al., 2008, 2011; Lund et al.,
2009), Moreover, the choice of appropriate control conditions
in clinical acupuncture trials on chronic pain syndromes poses
a particular challenge, given that it is not possible to blind the
acupuncturist. Double blinding is therefore essentially impossible
which, in turn, substantially increases the risk of bias. In their
recent review Chae et al. (2018) not only discuss the problems
associated with non-penetrating sham acupuncture devices but
also focus on the methodological challenges associated with trial
design while introducing possible solutions with their benefits
and shortcomings.
Several of the physiological mechanisms identified by
Chae et al. (2018) are liable to account for some of
the effects of placebo needles and cover the physiological
effects of penetrating sham acupuncture: tactile stimulation
is believed to be specific to the intervention and divided
into the sensory discriminative and affective social component
of the procedure. Some of the particularities of all forms
of acupuncture/sham acupuncture/minimal acupuncture is
the impossibility of blinding, possibly resulting in greater
expectation-related placebo effects than when using a placebo
pill. Nonetheless, expectation is also a neurophysiological effect
which originates in the brain and which thus exerts its
effect top-down.
POSSIBLE NEUROBIOLOGICAL
MECHANISMS OF ACUPUNCTURE AND
SHAM ACUPUNCTURE
C-Fiber Touch as Potential Mediator for
the Affective-Social Dimension of
Acupuncture
C-fiber touch (CT’s) are tactile low threshold mechanosensitive
fibers which are sensitive to gentle touch and which form a
second touch system, with pleasant touch as a modality. They are
assumed to represent the positive hedonic aspects of gentle touch
(McGlone et al., 2007, 2014; Abraira and Ginty, 2013; Musial and
Weiss, 2014). Thanks to animal experiments, this system has been
known for quite some time and its role for humans has already
been acknowledged. In humans, this system has been proposed to
represent the neurobiological substrate, inducing feelings of calm
and well-being related to gentle touch (McGlone et al., 2007, 2014;
Abraira and Ginty, 2013; Musial and Weiss, 2014).
The particular role of touch for humans is not new to us,
even though the particular C-fiber touch system has not yet
been fully described for humans. For example, holding hands
reduces the neural response to threat in an fMRI paradigm, even
if the person holding the hand is a complete stranger (Coan
et al., 2006). As Chae et al. (2018) point out, touch is a central
factor in many medical procedures and an integral factor in all
acupuncture conditions, regardless of whether or not the device
penetrates the skin.
The touch component per se therefore constitutes a distinct
neurobiological pathway, uncommon in all non-touch placebos
such as a placebo pill. Moreover, it is represented by a specific
pathway where the origin of stimulation is generated in the
periphery of the body and travels in a bottom-up fashion to the
brain. From here, it exerts a complex affective-emotional reaction
(McGlone et al., 2007, 2014; Abraira and Ginty, 2013; Musial
and Weiss, 2014). At the same time, this pathway is common
to all acupuncture control conditions, thereby threatening the
validity of virtually all of these conditions (Campbell, 2006;
Lund et al., 2009).
De qi and the Sensory-Discriminative
Aspects of Acupuncture
Inserting a needle and penetrating the skin is a stimulus of vital
importance. Such a procedure will stimulate pain pathways and
signal information of an injury, and is therefore recognized by
the brain as a potential threat to the body’s integrity. It therefore
comes as no surprise that acupuncture procedures induce the
strong and distinct activation of pain-related areas in the brain
(Zhao, 2008; Chae et al., 2013). According to Zhao “Acupuncture
analgesia is manifested only when the intricate feeling (soreness,
numbness, heaviness, and distension) of acupuncture in patients
occurs following acupuncture manipulation” (Zhao, 2008). This
sensation, known as de qi, is believed to be fundamental to
the therapeutic outcome of acupuncture (Choi et al., 2013;
Chae et al., 2018).
To date, several studies have shown that even non-
penetrating placebo needle procedures induce de qi sensations
that are indistinguishable from the effect of real acupuncture
needles (Chae, 2017; Chae et al., 2018). Taken together,
these findings indicate that even non-penetrating acupuncture
placebos are capable of stimulating sensory-discriminative
pathways, including pain sensation. The current evidence
therefore suggests that acupuncture – or indeed any other kind of
needling procedure – constitutes a nociceptive and/or pain signal:
Acupuncture (e.g., ST 36) activates pain-related brain structures
(Biella et al., 2001; Pariente et al., 2005; Beissner et al., 2012;
Theysohn et al., 2014); for overview and discussion see Wang
et al. (2008), Zhao (2008), and the activation is dependent on
the needling sensation (Beissner et al., 2012). Moreover, a meta-
analysis across 28 fMRI studies of acupuncture needling showed
an activation of the pain matrix (sensorimotor cortical network,
including the insula, thalamus, and anterior cingulate cortex
(ACC), as well as both the primary and secondary somatosensory
cortices) (Chae et al., 2013). In summary, there is ample evidence
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that acupuncture per se constitutes a nociceptive/pain stimulus
which influences brain networks in a bottom-up fashion.
Under the premise that the therapeutic acupuncture effects are
at least partly mediated through the pain pathway of the sensory-
discriminative system, the processing of nociceptive signals in
the spinal cord must be taken into account to explain the effect
of needling and its related de qi sensation. A needling stimulus
in a painful situation, be it clinically manifested such as in a
pain syndrome or experimentally induced in the laboratory, is
liable to excite two mechanisms on the level of the spinal cord:
segmental (gate-control) (Mayer et al., 2000; Irnich and Beyer,
2002; Stux et al., 2003) and spino-medullary (diffuse noxious
inhibitory control, DNIC) (Le Bars et al., 1989; Le Bars, 2002; Le
Bars and Willer, 2002, 2007; Le Bars and Cadden, 2007) processes.
While gate control is, neurophysiologically speaking,
somewhat short-lived (Fields et al., 2005), DNIC is a strong
long-term effect, inasmuch as it persists for several minutes
after its induction. Such a response is typical of neuroplastic
changes (Le Bars and Willer, 2002, 2007). DNIC characterizes an
intrinsic mechanism for inhibiting pain that becomes activated
when an additional nociceptive stimulus is applied to a region
far removed (heterotopic) from the initial region receiving
nociceptive stimulation (Le Bars et al., 1989; Le Bars, 2002; Le
Bars and Willer, 2002; Le Bars and Cadden, 2007; Le Bars and
Willer, 2007). This phenomenon is often classified under the
superordinate concept of “counter irritation” (Le Bars et al.,
1989) and is mediated via a spino-medullary loop (Le Bars, 2002;
Le Bars and Willer, 2007).
In humans, experimental paradigms which test the effect of
additional pain stimuli on an already existing experimental pain
stimulus, and which are thus homologous to DNIC are often
called “heterotopic noxious conditioning stimulations (HNCS)”
(Sprenger et al., 2011) or “conditioned pain modulation (CPM)”
(Bjorkedal and Flaten, 2012). Sprenger et al. (2011) used a
tonic cold pressor task and phasic additional pain stimulation
in an fMRI paradigm and noticed a clear HNCS effect with
marked endogenous analgesia. This outcome was accompanied
by reduced activity in classical pain-related brain structures and
the recruitment of an opiate-dependent, descending pain control
system (naloxone blockade). In women Bjorkedal and Flaten
(2012) were able to show that a CPM response can be reduced
by expectations.
Acupuncture has been shown to exhibit rather strong
effects in an HCNS/CPM design (Choi et al., 2011a,b; Musial
et al., 2012). Moreover, acupuncture decreased somatosensory-
evoked potential amplitude to noxious stimuli in anesthetized
volunteers in an HCNS/CPM design (Meissner et al., 2004),
thus showing clear acupuncture effects in unconscious humans.
This is an interesting observation, given that all cortical effects
such as expectations, suggestions, beliefs etc, can be excluded
as confounding factors in subjects under deep anesthesia.
Further evidence from fMRI studies shows less brain activity in
somatosensory areas in response to pain following acupuncture
stimulation (modulation of cold pain: (Zhang et al., 2003) and
electrical pain: (Theysohn et al., 2014).
In conclusion, acupuncture therapeutic effects are
seen to be related to the de qi sensation, which is
characterized as a pain-related sensation. There is evidence
that acupuncture and related conditions act via a pain
signal elicited in the periphery and traveling bottom-
up to the brain. These peripheral nociceptive signals
may undergo modulation via spinal and spino-medullary
mechanisms. Since virtually all placebo/sham acupuncture
procedures are known to induce de qi ensations that are
indistinguishable from real acupuncture, it should be borne in
mind that this pain-related, somatosensory-discriminative
mechanism akin to acupuncture is common to all true
acupuncture/sham acupuncture/minimal acupuncture, and
placebo acupuncture conditions.
Enhanced Expectation as a Mediator for
the Strong Effects of “Sham”- and
Placebo Acupuncture Conditions?
Despite various creative approaches such as the above
discussed non-penetrating placebo needles (Streitberger
and Kleinhenz, 1998; Park et al., 2002; Chae et al., 2018),
an adequate experimental control of acupuncture for the
treatment of chronic pain is scarcely possible, particularly
since the acupuncturist cannot be blinded. One of the
characteristics of all acupuncture and related procedures is,
therefore, the impossibility of blinding, which can lead to
greater expectation-related placebo effects than with other
placebos (for overview and discussion see Chae (2017),
Chae et al. (2018).
Expectation is a key mediator of the placebo response (Kirsch,
1999; Enck et al., 2008; Colloca and Miller, 2011a,b) and its
relevance for the clinical effectiveness has already been well
documented [(Moffet, 2009; Linde et al., 2010a; Chae et al.,
2018)]. Interestingly enough, while it is widely accepted within
placebo research that enhancing the placebo effect during drug
treatment is desirable (Enck et al., 2013; Evers et al., 2018), the
possibility that expectation – and thus placebo – may play a role
in clinical acupuncture effects has been held against acupuncture
as a treatment, in particular in public discourse. The argument
is that acupuncture may merely represent a “placebo” without
so-called “specific effects.” This is contradictory in view of
the fact that, physiologically speaking, the expectancy-mediated
placebo effect per se has meanwhile been reasonably well defined
and represents a rather distinct neurophysiological mechanism
(Enck et al., 2008; Wager and Atlas, 2015; Geuter et al., 2017;
Schafer et al., 2018).
The individual placebo response has been under close
scrutiny ever since the 1990s (Benedetti et al., 1995;
Benedetti, 1996; Amanzio and Benedetti, 1999; Benedetti
et al., 2005). In an experimental pain-tolerance setting,
Benedetti et al., showed how conditioning and expectation
processes both play a role in placebo analgesia. The expectation-
induced placebo response can be completely blocked by the
opioid antagonist naloxone (Benedetti, 1996), whereas the
conditioning-dependent placebo response can be blocked by
naloxone only when conditioning was carried out with an
opioid (Amanzio and Benedetti, 1999). Thus, expectation-
dependent placebo responses are, in principle, mediated by the
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endogenous opioid system, whereas conditioning-dependent
placebo effects depend on the particular subsystem that
had been conditioned. The opioid-dependent mechanism of
expectation-induced placebo analgesia is also supported by
neurophysiological imaging studies in man, showing that
an opioid-dependent cortical network becomes activated
during a placebo response (Petrovic et al., 2002; Zubieta et al.,
2005). Acupuncture analgesia is similar to the expectation-
dependent placebo effect in that it too can be blocked by
naloxone, i.e., it is also opioid-dependent [for an overview,
see (Mayer et al., 2000)].
ACUPUNCTURE, PLACEBO, AND THE
PAIN MATRIX
Data from imaging studies have confirmed that not only
expectation but also learning and context factors play a role
in placebo effects [for overview and discussion see Enck et al.
(2008), Wager and Atlas (2015), Geuter et al. (2017), Schafer
et al. (2018)]. Moreover, context and social factors are welcome
modulators for expectation and associative learning. Most of
these models are based on results from pain studies.
With regard to the placebo response, the ventromedial
prefrontal cortex (vmPFC), the dorsolateral prefrontal cortex
(dlPFC), the lateral orbitofrontal cortex (lOFC), nucleus
accumbens, insula, amygdala, hypothalamus, and periaqueductal
gray are generally regarded as crucial (Wager and Atlas, 2015;
Geuter et al., 2017; Schafer et al., 2018). All these areas increase
activity in response to placebo manipulations related to pain
stimulation (Wager and Atlas, 2015), albeit the periaqueductal
gray (PAG) and the dorsal anterior cingulate cortex (dACC)
respond in a more differentiated fashion, and appear to have
a modulatory function within the placebo network (Wager and
Atlas, 2015). The vmPFC seemingly plays a particularly essential
role in the mediation of expectation (Geuter et al., 2017). Thus,
the vmPFC represents the part of the placebo brain network
that connects situational factors to neurophysiological responses
(Geuter et al., 2017).
At the same time, the placebo network appears to be
independent from the pain network, even though some
structures, primarily the PAG and the dACC, seem to have
a modulatory function in both networks (Wager and Atlas,
2015; Geuter et al., 2017). This conceptualization fits well
with a number of experimental findings, indicating that the
perception of pain is also dependent on the context (Keltner
et al., 2006). In one fMRI study, for instance (Koyama
et al., 2005) were able to show that, to a great extent, the
expectation of one particular stimulus intensity determined its
cortical representation, regardless of whether or not it was
anticipated to be painful. As the magnitude of the expected
pain increased, activation increased simultaneously in the
thalamus, insula, prefrontal cortex, and ACC. Pain-intensity-
related brain activation was identified in a widely distributed set
of brain regions and overlapped partially with expectation-related
activation in other regions, including the anterior insula and ACC
(Koyama et al., 2005).
Thus, the evidence available with regard to placebo effects on
pain in experimental human and animal studies suggests that
placebo effects are mediated by a network of brain structures
that differ from the pain network. However, the placebo
network influences and modulates the pain network, relying on
several factors such as context, learning and prior experiences,
instructions, etc. These factors probably influence the placebo
network by way of expectations. Expectations are fundamental
inasmuch as they may signal reward (e.g., reduced pain).
Anticipated reward will activate the reward system in the brain,
a system that involves the nucleus accumbens, the amygdala, the
ventral tegmental area, and the orbitofrontal cortex (Enck et al.,
2008). The neurotransmitters of this system are dopamine and
opioid peptides, and this network is usually investigated with
regard to drug dependencies and reinforcement. In summary,
instructions, suggestions, and other types of social information
can have powerful effects on pain and these changes are mediated
by top-down control via the involvement of prefrontal regions,
particularly the dorsolateral and ventromedial prefrontal cortex
(Koban et al., 2017).
As already elucidated, current evidence suggests that any
kind of needling procedure constitutes a nociceptive and/or pain
signal (Biella et al., 2001; Pariente et al., 2005; Beissner et al.,
2012; Theysohn et al., 2014); for overview and discussion see
Wang et al. (2008), Zhao (2008), Beissner et al. (2012), and that
acupuncture needling (a meta-analysis across 28 fMRI studies)
induces an activation of the pain matrix (sensorimotor cortical
network, including the insula, thalamus, anterior cingulate
cortex, and both primary and secondary somatosensory cortices)
(Chae et al., 2013). Moreover, data from healthy humans subjects
in response to needling of commonly used acupuncture points
for the treatment of pain syndromes (manual acupuncture at
LI4, ST36) revealed a partial overlap with the pain matrix as
well as a deactivation of a limbic-paralimbic-neocortical network
(Hui et al., 2009; Claunch et al., 2012). This limbic deactivation
is correlated to the psychophysical response modulating the
bottom-up nociceptive signal. It therefore modulates brain
networks in response to acupuncture stimulation. Assuming
that acupuncture is a pain stimulus that travels bottom-up
and activates the pain networks, it must also be assumed that
expectations, instructions, emotions, and other context factors
modulate acupuncture effects.
In an elegant study Lee et al. (2015) modulated and
manipulated an acupuncture stimulus by instruction. One group
was told that the needling was part of an acupuncture treatment,
whereas the other group was informed about the needle insertion
only, and that this might be a painful intervention. In addition
to their acupuncture stimulation, all participants received the
same sensory stimuli which included a pain stimulus. The brain
activation in response to the pain stimulus in parts of the
pain network was significantly lower in those participants who
had been informed that the needle insertion was part of an
acupuncture treatment. At the same time, the needling within
a therapeutic context activated reward circuits in the brain and
modulated the pain matrix.
The results from brain imaging studies emanating from
placebo research as well as the results of Chae et al. (2013) and
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Lee et al. (2015) suggest that: (i) the pain matrix and the placebo
network are primarily independent brain networks; (ii) the pain
matrix and the placebo network interact and the placebo-induced
modulation of the pain-matrix is mediated by expectation; (iii)
acupuncture activates the pain matrix and is a nociceptive/pain
stimulus, and (iv) acupuncture as a nociceptive/pain stimulus is
modulated by placebo effects, in particular expectation.
Nonetheless, how powerful the modulation of the pain-
matrix through placebo effects actually is remains to be
elucidated. A meta-analysis of individual participant functional
magnetic resonance imaging data combined the results of
603 healthy individuals from 20 studies and investigated
the effects of placebo intervention on the pain matrix
(Zunhammer et al., 2018). The analysis revealed rather
moderate analgesic effects on subjective pain reports and only
a very small effect of the placebo condition on the pain
matrix. The authors concluded that placebo treatments affect
pain through brain mechanisms (top down) and that these
influences are largely independent from the bottom-up effects of
nociceptive processing.
IS ACUPUNCTURE A MEGA-PLACEBO?
ON THE RELATIVITY OF PLACEBO
In particular the neurobiological developments in the
understanding of the mechanisms of the placebo response
have confirmed that the concept placebo encompasses a wide
variety of modalities such as emotions, instructions, suggestions,
and other types of social information mediated by alterations
in prefrontal brain areas (Koban et al., 2017). These factors
are often described as the “unspecific” effects of a particular
treatment setting, indicating that the treatment effects are
mainly psychological in nature and independent from the
treatment provided.
To date, the concept of specificity at brain level, which
is reminiscent of the historic theory of phrenology, may be
questioned. Defined brain areas, such as the PAG or the dACC
play a role in a number of brain functions. This fact tallies
well with the concept that brain functions are performed by
the activity of neural networks. The concept of neural networks
also explains why the perception of pain is context-dependent
(Koyama et al., 2005; Keltner et al., 2006); a finding that is relevant
for the explanation of pain-related placebo effects.
Howick (2017) proposes a broader definition of placebo which
goes beyond the claim that a placebo should consist of an inert
“intervention simulation.” His modified version of Grünbaum’s
definition of placebo emphasizes the role of expectations, and
thus includes emotions, learning, and other contextual variables.
Moreover, his definition assigns a special role to the peculiarities
of a treatment situation, including special treatment features, and
thus partly allows for a contextual definition of placebo. However,
it is worth bearing in mind that Grünbaum’s original article
(Grunbaum, 1986), which relates to placebo effects in psychiatry
and psychotherapy, remains somewhat controversial (Enck and
Zipfel, 2019). To what extent this concept can be applied to other
non-pharmacological treatments such as acupuncture – which is
in many ways more “physical” than psychotherapy – may not be
entirely consensual in the field of placebo research.
Nonetheless, Howick’s interpretation of Grünbaum’s
definition (Grunbaum, 1986) provides an opening for the
role of treatment theory and thus calls for a broadening of the
definition of placebo beyond the role of expectation. In his paper,
Howick (2017) uses the acupuncture/sham acupuncture/placebo
needle discussion as a case study to illustrate that treatment
theory is fundamental to the definition of a placebo condition
and that it does not suffice to control exclusively for expectation.
In his example, point specificity as treatment theory will lead
to an acupuncture-related placebo concept which interprets
needling at non-acupuncture points as “placebogenic” [page
1371, Howick (2017)]. In his case study on acupuncture, he
argues that independent evidence supports the assumption
that the placebo needle itself (Streitberger needle) cannot be
a true placebo. He pinpoints that the core challenge in the
interpretation of the clinically effective control procedures for
the acupuncture treatment of pain states is the lack of an accepted
therapeutic theory for acupuncture.
Howick’s broadened concept of placebo not only
allows for the defined use of placebo controls beyond
the pharmacological context but also includes also non-
pharmacological interventions. Nonetheless, as he demonstrates
in his acupuncture case study, his definition demands and
includes a defined therapeutic theory. With regard to many
interventions out of the spectrum of complementary and
alternative medicine, this may still constitute a challenge,
such as in the case of acupuncture. Further clinical studies
addressing treatment theory of acupuncture as well as the
placebo/expectation issue are therefore required.
The field of placebo research has accepted that placebo might
not be as distinctively defined as it is necessary for conducting a
clinical trial in the non-pharmacological arena. Placebo effects are
viewed as positive and useful factors of a treatment, particularly
in clinical practice, and are considered to be a part of every regular
treatment (Evers et al., 2018). With this definition, the debate
as to what extent a treatment is dependent on placebo becomes
less pungent and the focus is relocated to the most important
question, namely to: what helps patients, what relieves their pain,
and how can they be treated most effectively. This pragmatic
approach aims to maximize all the positive factors of a treatment
that can be recruited while minimizing risk and negative effects,
including nocebo (Evers et al., 2018).
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